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1. Abstract
Background 
Patients with foot and ankle trauma treated with cast are advised to perform 
toe movements to prevent venous thromboembolism (VTE). Our aim was to 
determine the effect of active toe movement on asymptomatic deep vein 
thrombosis (DVT) and venous calf pump function. 
Methods 
Patients aged 18 to 60 years with acute foot and ankle trauma requiring below 
knee non weight bearing cast were randomized to intervention (regular active 
toe movement) or control groups (n=100). Patients had bilateral lower limb 
venous ultrasound to assess for DVT on discharge from clinic. Patients 
requiring chemical thromboprophylaxis were excluded. 
Results 
78 completed the study. 27% sustained asymptomatic DVT, with no 
statistically significant difference in calf pump function or DVT incidence 
between groups. All DVT’s occurred in the injured lower limb. 
Conclusion 
Active toe movement is not a viable strategy for thromboprophylaxis in 
patients with acute foot and ankle trauma treated with cast. 
Keywords: Thromboprophylaxis, Venous thrombosis, Deep vein thrombosis 
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2. Introduction 
 
Thromboprophylaxis is clinically and financially beneficial compared with 
treatment of thromboembolic events once they have occurred [1]. In patients 
with foot and ankle trauma treated with cast, thromboprophylaxis significantly 
reduces venous thromboembolism rate, with thirteen patients requiring 
prophylaxis with low molecular weight heparin to prevent one asymptomatic 
DVT [2-4].  Considering that chemical thromboprophylaxis for patients with 
lower limb cast immobilisation represents 5.3% of the outpatient tariff for 
trauma, this represent a significant cost [5]. This also represents a potential 
risk, in view that chemical thromboprophylaxis can cause major bleeding [6]. 
Patients with foot and ankle trauma treated with casts are also advised to 
participate in activities of early mobilisation and calf pumping exercises to 
reduce their risk of developing DVT [7]. Although we have previously shown 
that active toe movement increases venous velocities in the popliteal vein in 
healthy volunteers, even with a below knee cast applied, the clinical 
importance of these findings requires further investigation [8,9]. Most studies 
rule out mechanical thromboprophylaxis in patients with below knee casts for 
various reasons [10, 11]. However, considering that venous stasis is thought 
to contribute to thrombogenesis, it is possible that regular active toe 
movement (AToM) could reduce the development of deep vein thrombosis in 
patients with injury and cast treatment [12]. Our primary aim was to determine 
the effect of regular active toe movement (AToM) on rates of asymptomatic 
DVT in patients with acute foot and ankle trauma treated with cast and define 
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which venous segments were involved. Our secondary aim was to determine 
the effect of regular active toe movement on calf pump function. 
 
3. Methods 
 
In this prospective randomized controlled study, adult patients with acute foot 
or ankle trauma treated with below knee cast at the University Hospital of 
Wales between 18th February 2014 and 21st January 2015 were recruited. 
The local Ethics committee and Research and Development department 
approved this study. The study was registered on UK Clinical Research 
Network Portfolio Database (UKCRN ID: 17648. http://public.ukcrn.org.uk). 
Funding for consumables to conduct this study was provided by AO UK. In 
accordance with NICE guidance and local hospital protocols, all patients were 
assessed for risk of venous thromboembolism. If patients had any permanent 
risk factors for VTE they were not eligible for the study and were provided with 
Low molecular weigh heparin (Enoxaparin) thromboprophylaxis 40mg 
subcutaneous injection once daily and were not eligible for study participation. 
Patients currently taking Warfarin or Heparin for any other reason were also 
excluded.  
 
3.1 Exclusion criteria 
 
Risk factors for VTE (exclusion criteria) were: Age >60 years, Current 
hormone therapy (Oral Contraceptive Pill, Hormone Replacement Therapy, 
Tamoxifen), Personal or first degree relative VTE history, Any recent hospital 
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admission or major surgery (within 3 months), Pregnancy or immediate 
postpartum (6 weeks), Any serious medical co-morbidity (including congestive 
cardiac failure, chronic obstructive pulmonary disease, chronic kidney 
disease, inflammatory bowel disease), Extensive varicosities, Active cancer, 
Obesity (BMI over 30 kg/m2), Known thrombophilia, Achilles tendon rupture, 
Equinus cast. All patients assessed as ‘low risk’ based on this risk 
assessment were potentially eligible for the study and were referred to the 
Chief Investigator for review in the next available fracture clinic. On review in 
clinic, VTE risk assessment was repeated to confirm patients were ‘low risk’ 
and eligible for the study. Patients who were anticipated to be treated in a 
backslab or cast for less than 1 week were not recruited. Patients with injuries 
requiring surgery were also not recruited because these patients are provided 
with Low Molecular Weight Heparin. Patients presenting more than 72 hours 
after initial injury were excluded. 
 
3.2 Study design and intervention 
 
The Chief Investigator recruited all patients. After consenting for participation 
in this study, patients were allocated to either the intervention (AToM) or 
control group according to a pre-defined computerized randomization 
sequence with variable block sizes. Patients were not informed of their 
randomization allocation group and all assessments of calf pump function and 
ultrasound for deep vein thrombosis were performed by medical physicists 
who were blinded to the randomization allocation. Participants who were 
allocated to the intervention group were provided with an active toe movement 
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protocol to follow, with a compliance diary to complete. Patients allocated to 
the intervention group were instructed to perform full active toe flexion and 
extension movement exercises at the metatarsophalangeal and 
interphalangeal joints as often as possible, with prescriptive advice to perform 
these movements at a minimum of 60 movements every 6 hours. Patients 
were managed in fracture clinic depending on their injury until discharge. 
Patients were shown how to perform these simple exercises and provided 
with written advice. 
 
3.3 Outcome measures 
 
When the patient no longer required their below knee cast or boot 
immobilization as part of their treatment they attended the Medical Physics 
department for assessment of calf pump function and bilateral above and 
below knee venous Duplex scanning to screen for asymptomatic deep vein 
thrombosis. Historically, venography was used to screen for DVT’s, however 
current clinical practice is to use Duplex ultrasonography. This has previously 
been used in other similar studies [13]. Any patient who was discharged from 
clinic prior to having Duplex scanning was sent an appointment letter to attend 
for Duplex scanning. Senior Medical Physicists who work within the National 
Health Service and perform these scan on patients routinely performed all 
scans. If a deep vein thrombosis was present on Ultrasound scanning, the 
anatomical location and laterality in relation to the injured limb was recorded. 
The patient exited the study at this stage. Patients with positive Doppler scans 
for DVT were provided with treatment if the DVT was located in the above 
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knee veins (Popliteal or more proximal). Patients with DVT in the below knee 
veins had a repeat Duplex scan a week later to assess for resolution or 
propagation of the DVT.  
 
In patients who did not sustain deep vein thrombosis, calf pump function was 
assessed using Doppler ultrasonography according to a standardized 
protocol. With the patient seated with hips and knees at 90 degrees flexion, 
baseline popliteal velocity was measured in the popliteal vein after cast 
removal, using Doppler ultrasound at rest. Each patient then performed 3 
consecutive active toe dorsiflexion exercises starting with the toe in neutral 
position, with a rest of 30 seconds between to allow for venous refilling. Peak 
popliteal velocity was recorded during active toe movement and the mean 
was calculated. Peak velocity was then recorded during active toe 
plantarflexion. This method has previously been used to assess calf pump 
function in healthy volunteers with and without lower limb cast applied [8]. 
 
3.4 Statistical analysis 
 
A power calculation was based on the prediction that asymptomatic DVT 
would occur in 21.9% of patients with an anticipated intervention effect size of 
63% reduction [14]. To allow for 5% withdrawal rate after randomization it was 
planned to randomize 150 patients to each group to achieve 80% power. To 
ensure randomization worked, baseline characteristics were analysed using t 
tests for continuous variables and chi square tests for proportions. Shapiro 
Wilk test was used to test for normality of calf pump function data and 
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analysis of non parametric results was performed with Mann Whitney U test. 
A generalization of the Mann Whitney U statistic was also performed to 
determine the effect size of AToM on calf pump function [15]. All statistical 
analysis was performed using SPSS for Windows (SPSS, Chicago, Illinois). 
Analysis of DVT outcomes between groups was performed using Chi square 
test.  
 
4. Results 
 
During the recruitment, 342 patients between the ages of 18 and 60 years had 
injuries treated with below knee casts, 242 were excluded prior to 
randomization. 100 patients entered the study and were randomized to 
intervention (AToM) or control groups. 78 patients completed the study 
(Figure 1). There were no significant differences between the groups (Table 
1). 22 (56%) of the patients randomized to the AToM group returned a fully 
completed toe movement activity diary with number of active toe movements 
recorded for each day during cast or boot treatment. 13 (59%) of these 
patients recorded that they achieved the minimum number of active toe 
movements (240) per day (range 16-600). 4 (31%) of these patients sustained 
asymptomatic DVT. There were no reported adverse events. 
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4.1 Calf pump function 
 
After 100 patients had been recruited, analysis of the calf pump function 
between groups was performed to determine whether the intervention had 
any statistically significant effect on baseline or peak popliteal velocities. Calf 
pump function data was not normally distributed, and was analysed using 
Mann-Whitney test. (15,16) The U/nm statistic of 0.572 (95% CI 0.420 – 
0.710) for both active toe dorsiflexion and active toe plantarflexion indicated 
that patients in the intervention group generally had greater peak velocities 
during these movements, however the effects were small (Table 2). The mean 
baseline popliteal vein diameter was 7.9mm in both groups. Although baseline 
popliteal velocity, peak velocity during active toe dorsiflexion and peak 
velocity during active toe plantarflexion were greater in the AToM group 
patients, none of these differences were statistically significant (Table 3). 
 
4.2 Asymptomatic DVT 
 
In view that AToM did not statistically significantly influence calf pump function 
in patients, it was decided by the Chief Investigator with agreement of the 
steering committee to request an interim analysis of the effect of the 
intervention on asymptomatic deep vein thrombosis. At this stage in the study, 
the overall event rate was 33.3% (n=13) in intervention and 20.5% (n=8) in 
control. Interim analysis found the confidence interval of the proportions 
ranged from 6.9% asymptomatic DVT reduction in the intervention to 31% 
increased incidence of asymptomatic DVT in the intervention group [16]. In 
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view that the anticipated effect size was a 63% asymptomatic DVT reduction 
in the AToM intervention group, it appeared that the intervention was less 
effective than expected and the steering committee decided to stop 
recruitment [17]. 
 
4.3 Incidence and anatomical location of asymptomatic Deep Vein 
Thrombosis 
 
Overall, 21 (27%) patients were found to have asymptomatic deep vein 
thrombosis on ultrasound examination (Table 4). All of these occurred in the 
lower limb that had been injured and treated in cast. The DVT rate was 13/39 
(33.3%) in intervention group, 8/39 (20.5%) in control group. These 
differences were not statistically significant (p=0.202). 3 DVT’s were above 
knee and were treated for oral anticoagulants for 3 months. In all patients 
except 2, the peroneal vein was thrombosed. In 12 patients the DVT was an 
isolated peroneal DVT. 4 patients had combined peroneal and posterior tibial 
vein DVT, 1 patient had isolated posterior tibial vein DVT, 2 had popliteal vein 
DVT which appeared to arise from the peroneal vein, 1 patient had isolated 
popliteal vein DVT. The mean age of patients who sustained DVT was 36 
years (range 21 to 53) with a mean BMI of 25kgm2 (range 19.7 to 30.4). 13 
were male (65%). There was no statistically significant difference between 
age or BMI between patients who sustained DVT and those who did not.  
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5. Discussion 
 
This is the first study to examine the effects of active toe movement on DVT in 
patients with foot and ankle trauma treated with cast. Although we have 
previously shown that active toe movement (AToM) can influence calf pump 
function in healthy volunteers with below knee casts applied, we were unable 
to find any evidence that this reduces the incidence of DVT [8]. We 
anticipated that patients who performed regular active toe movements would 
have had improved venous calf pump function parameters, however this 
intervention had no significant effect.  
The concept that lower limb muscular contraction can influence thrombosis is 
not new. In a prospective randomized study performed almost 20 years ago, 
38 patients who underwent total hip replacement were randomized to a 
standardized foot and ankle movement protocol and venous plethysmography 
was performed 4 days postoperatively [18]. Venous outflow was increased by 
22% in the intervention group and it was recommended that regular foot and 
ankle exercises should be part of a prophylactic regimen against venous 
thrombosis [18]. Although these exercises may have influenced calf pump 
function, there was no further study conducted to investigate the effects on 
deep vein thrombosis. Similarly, Kaplan et al (2002) found that electrical 
stimulation of the foot or calf muscles increased popliteal and femoral vein 
velocities, but failed to investigate the effects on DVT [19]. More recently, 
Fuchs et al (2005) conducted a prospective randomized controlled trial of 227 
trauma patients with bony or ligamentous trauma to the spine, pelvis including 
acetabulum, femur, tibia or ankle [20]. All patients received unfractionated 
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heparin, however the intervention group also received mechanical 
thromboprophylaxis with an ankle continuous passive motion machine 
(Arthroflow) for 30-minute sessions, three times per day (30 movements per 
minute, range of motion 20 degree dorsiflexion to 40 degrees plantarflexion). 
Asymptomatic DVT diagnosed on ultrasound or venogram was significantly 
reduced in the Arthroflow group, from 25% to 3.6% (p=0.001). Whitelaw et al 
(2001) compared the haemodynamic effects of 6 different mechanical 
thromboprophylactic devices on calf pump function and found that there was 
no statistically significant difference in increases in peak velocity between the 
most effective device (AirCast VenaFlow) and active or passive dorsiflexion 
[21]. An early prospective randomized controlled trial of 290 patients who 
underwent total hip replacement, confirmed that not only did AV foot pumps 
influence popliteal venous velocities, but also reduced asymptomatic DVT to 
rates comparable to levels achieved with low molecular weight heparin [22]. 
Since then, intermittent pneumatic compression has been found to reduce 
symptomatic DVT (from 16.7% in control group, to 7.3% in IPC) and 
pulmonary embolism (from 2.8% to 1.2%) at meta-analysis level of 70 studies 
including over 16000 medial and surgical patients [23]. It is also effective in 
reducing VTE in patients with hip fracture, patients undergoing total knee 
replacement and following stroke, all of which are considered high risk VTE 
groups [24, 25, 26].  
 
Considering that active toe movement influences venous haemodynamics in 
healthy volunteers to a similar extent to intermittent pneumatic compression 
foot pump devices, we anticipated that this may also reduce asymptomatic 
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DVT in patients with casts [8, 21]. One of the main reasons why AToM failed 
to reduce DVT rates may relate to the relative infrequent performance of 
exercises by patients. In our AToM study, participants in intervention group 
performed 60 sets of movements 4 times per day, which equates to 240 sets 
in a 24 hour period. In comparison to patients using A-V foot pumps in the 
study by Warwick et al (1998) used them for a median of 15 hours in a 24 
hour period at a 20 second cycle, equating to approximately 2700 
compressions [22]. This is more than 10 times the number of compressions 
participants in the AToM study would have performed. To achieve this with 
AToM, assuming patients sleep for approximately 8 hours and would be 
awake for 16 hours per day, participants would need to perform almost 170 
sets of AToM per hour to achieve a similar amount of compression. 
Considering that many patients in our study were unable to achieve even the 
minimum suggested number of active toe movements (240 in 24 hours) and 
that none of them reported performing more than 600 active toe movement 
exercises in a 24 hour period it is unlikely that a patient would be able activate 
their calf pump as frequently as an AV foot pump. Therefore, although the 
effect of active toe movement on popliteal velocities is similar to the effect of 
AV foot compression devices, there is a great difference in the number of calf 
pump activations performed [21]. 
Considering that all patients were risk assessed for VTE and all were 
considered low risk, we were surprised to find that 27% of all patients were 
found to have an asymptomatic DVT on lower limb ultrasound examination. It 
appears therefore that current risk assessment tools fail to identify a 
significant proportion of patients who will develop asymptomatic venous 
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thrombosis. An important finding is that all of these venous thrombosis 
occurred in the lower limb that had been injured and treated in cast. 
Furthermore, the majority of these events occurred in the peroneal veins 
(90%). In view of this, interventions to reduce venous stasis in these patients 
may be more effective if they aim to reduce stasis in the peroneal veins, by 
stimulation of the musculature in the peroneal compartment of the injured, 
casted leg. Our intervention focused on active flexion and extension exercises 
of the great toe, thereby using flexor and extensor halluces longus to 
influence calf pump mechanics. These muscles are located in the deep 
posterior and anterior compartments of the leg, which may be a reason why 
these exercises did not influence the incidence of peroneal vein thrombosis. 
Other potential thromboprophylactic exercises could have included knee 
flexion and extension to utilize contraction of gastrocnemius, which attaches 
proximal to the knee joint. However, these muscles are located in the 
superficial posterior compartment of the leg and may also fail to influence 
stasis in the peroneal veins. This requires further study. To minimize the 
potential for venous stasis, minimizing the time duration of rigid cast treatment 
and using the least immobilizing cast/boot the injury will allow, may also 
influence venous thrombosis rates. 
 
In view that the patient demographics in each study group were similar, it 
appears that the randomization sequence used in our study was effective. 
This is important, because unknown confounding factors are likely to have 
also been similar between groups [27]. We achieved almost 80% follow up, 
which is higher than many previous randomized controlled studies of 
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thromboprophylaxis in a similar patient group [28, 29, 30]. It has previously 
been acknowledged that co-ordination of studies to reduce the risk of VTE is 
challenging due the fact that patients with lower limb casts present and are 
treated in several areas within the hospital e.g. Emergency department, 
fracture clinic [31]. Although our intervention was relatively simple, this means 
our findings have good external validity. It has previously been suggested that 
prospective randomized controlled trials are at risk of lacking external validity 
due to highly intensive or regimented intervention protocols [32]. Although 
only 33% of patients in the intervention group reported achieving the minimum 
recommended number of active toe movements, this is an effectiveness study 
which assesses how the intervention works in the real world [27]. Although 
multiple practitioners performed assessment for DVT, all had a minimum of 5 
years experience in the NHS performing these scan as part of their clinical 
practice. None of the ultrasound scans for DVT were likely to be false 
positives in view that all were still positive on repeat scanning after a week 
interval. All assessors of DVT were blinded to the patient randomization 
group. 
 
We acknowledge several limitations of our study. Firstly, we were only able to 
recruit 100 (26%) patients after screening 380 for eligibility, due to the current 
NICE guidelines that recommend chemical thromboprophylaxis for patients 
with lower limb trauma treated with cast with additional risk factors. This 
meant that none of the patients who underwent surgery could be included (n= 
105), with an additional 72 patients being prescribed LMWH for other reasons. 
We were also unable to recruit patients over the age of 60 years of age 
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(n=97) during the study period because this is also considered to increase 
VTE risk in patients with lower limb trauma treated with cast [6].  
 
In conclusion, regular active toe movement by patients treated with lower limb 
cast for acute foot and ankle trauma did not significantly influence calf pump 
function or reduce the incidence of asymptomatic deep vein thrombosis. All 
cases of deep vein thrombosis occurred in the lower limb, which had been 
injured and treated in cast. The majority (90%) of venous thrombosis involved 
the peroneal veins. Advice to patients to perform regular active toe movement 
alone appears insufficient to reduce the risk of development of asymptomatic 
deep vein thrombosis.  
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Table 1: Characteristics of participants 
Characteristics AToM (N = 39) Control (N = 39) 
Age (mean) 36.6 (18-60) 36.8 (18-60) 
Male sex, n (%) 23 (59) 28 (72) 
Bony injury, n (%) 36 (92) 36 (92) 
Injuries, n   
     Ankle fracture –Weber A 7 8 
     Ankle fracture – Weber B 15 16 
     Ankle sprain 3 3 
     Anterior process of calcaneus fracture 1 0 
     Cuboid fracture 1 1 
     Distal fibula avulsion fracture 1 0 
     Dorsal talonavicular ligament avulsion 3 1 
     Fifth metatarsal fracture 1 2 
     Lateral process of talus fracture 1 1 
     Lisfranc injury 0 1 
     Medial malleolus fracture 4 5 
     Navicular fracture 1 1 
     Posterior malleolus fracture 1 0 
Duration of cast or boot, mean +/- SD (days) 42.7 (13.8) 39.6 (17.0) 
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Table 2: Mann Whitney U statistic analysis of calf pump function parameters 
(U/mn) 
 
 U/mn 95% confidence limits 
Lower Upper 
Baseline popliteal vein diameter - 
injured/cast leg 
0.495 0.349 0.642 
Baseline popliteal vein velocity - 
injured/cast leg 
0.533 0.384 0.676 
Peak velocity during active toe 
dorsiflexion (average) - injured/cast leg 
0.572 0.420 0.710 
Peak velocity during active toe 
plantarflexion (average) - injured/casted 
0.572 0.420 0.710 
 
Table 3: Calf pump function results 
 
Calf pump function parameter AToM Control p-value 
Baseline popliteal vein diameter (mm) 
 
7.9 (1.736) 7.95 (SD 2.084) 0.933 
Baseline popliteal vein velocity  
(cm/s) 
7.33 (3.663) 6.8 (2.193) 0.579 
Peak popliteal velocity during active toe 
dorsiflexion (cm/s) 
44.04 (30.172) 34.20 (18.878) 0.361 
Peak popliteal velocity during active toe 
plantarflexion (cm/s) 
39.04 (23.699) 31.70 (16.398) 0.348 
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Table 4: Asymptomatic Deep Vein Thrombosis events 
 AToM (N=39) Control (N=39) 
Asymptomatic DVT in Popliteal vein or more proximal 1 2 
Asymptomatic below knee DVT details:   
          Peroneal vein 8 5 
          Posterior tibial vein 1 0 
          Peroneal and posterior tibial veins 3 1 
Total n (%) 13 (33.3) 8 (20.5) 
 
Figure 1
Click here to download high resolution image
The effect of active toe movement (AToM) on calf pump function and deep 
vein thrombosis in patients with acute foot and ankle trauma treated with cast 
– A Prospective Randomised Study 
 
 
 
Highlights: 
 
There is no current evidence that active toe movement reduces asymptomatic 
venous thromboembolism in patients with foot and ankle trauma treated with 
below knee cast 
 
27% (n=21) of patients with acute foot and ankle trauma treated with below 
knee cast will develop asymptomatic deep vein thrombosis despite being 
assessed as low risk for thrombosis (above knee DVT incidence of 4% (n=3) 
 
90% (n=19) of asymptomatic deep vein thrombosis events in this patient 
group involve the peroneal vein 
 
All cases of asymptomatic deep vein thrombosis occur in the lower limb that is 
treated with below knee cast 
 
 
 
 
 
 
*Highlights (for review)
The effect of active toe movement (AToM) on calf pump function and deep 
vein thrombosis in patients with acute foot and ankle trauma treated with cast 
– A Prospective Randomised Study 
 
 
 
Conflicts of interest statement: 
 
None 
Conflict of Interest Statement
